<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ClinCalc</title>
	<atom:link href="http://clincalc.com/blog/feed/" rel="self" type="application/rss+xml" />
	<link>http://clincalc.com/blog</link>
	<description>Clinical tools and calculators for medical professionals</description>
	<lastBuildDate>Sun, 23 Aug 2015 12:15:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=4.3.1</generator>
	<item>
		<title>New Colistin (colistimethate sodium) Calculator</title>
		<link>http://clincalc.com/blog/2015/08/new-colistin-colistimethate-sodium-calculator/</link>
		<comments>http://clincalc.com/blog/2015/08/new-colistin-colistimethate-sodium-calculator/#comments</comments>
		<pubDate>Sun, 23 Aug 2015 12:15:29 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[ClinCalc News]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Pharmacokinetics]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=339</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2015/08/1280px-Pseudomonas_aeruginosa_culture-150x150.jpg" class="attachment-thumbnail wp-post-image" alt="Pseudomonas aeruginosa nutrient agar" style="float: left; margin-right: 5px;" />Colistin (in the form of colistimethate sodium, or CMS, in the United States) is an older, last-line agent for multidrug-resistant gram-negative infections.  Because of colistin&#8217;s complex pharmacokinetics and for historical reasons, there is a paucity of data regarding its dosing in patients with severe gram negative infections, particularly for those with concurrent renal dysfunction. In one of [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2015/08/new-colistin-colistimethate-sodium-calculator/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>It’s Time to Say “Goodbye” to Vitamin D2 (ergocalciferol)</title>
		<link>http://clincalc.com/blog/2015/07/vitamin-d2-ergocalciferol-vs-d3-cholecalciferol/</link>
		<comments>http://clincalc.com/blog/2015/07/vitamin-d2-ergocalciferol-vs-d3-cholecalciferol/#comments</comments>
		<pubDate>Sun, 19 Jul 2015 18:38:16 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[Clinical Questions]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=327</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2015/07/ergocalciferol_prescription-150x150.jpg" class="attachment-thumbnail wp-post-image" alt="Prescription bottle of ergocalciferol (Vitamin D2) 50,000 IU" style="float: left; margin-right: 5px;" />In the United States, vitamin D supplementation is primarily available as vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Although these two have historically been considered interchangeable and equipotent, the current body of literature strongly supports the preference of Vitamin D3 (cholecalciferol) over D2 (ergocalciferol). Vitamin D2 versus Vitamin D3 Vitamin D3 (cholecalciferol) is produced by [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2015/07/vitamin-d2-ergocalciferol-vs-d3-cholecalciferol/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vancomycin Calculator Update &#8211; End of Infusion Peak (EoIP)</title>
		<link>http://clincalc.com/blog/2015/06/vancomycin-calculator-eoip/</link>
		<comments>http://clincalc.com/blog/2015/06/vancomycin-calculator-eoip/#comments</comments>
		<pubDate>Sun, 07 Jun 2015 16:33:11 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[ClinCalc News]]></category>
		<category><![CDATA[Pharmacokinetics]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=302</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2015/06/Tinfusion_crop-150x150.png" class="attachment-thumbnail wp-post-image" alt="" style="float: left; margin-right: 5px;" />We&#8217;re releasing a major update to the calculation for our popular vancomycin calculator today. Briefly, the new update implements more advanced calculations when adjusting a vancomycin dose based on a trough level. Drug Elimination during Vancomycin Infusion When adjusting vancomycin based on a trough level, pharmacokinetic textbooks recommend estimating a vancomycin peak level using the [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2015/06/vancomycin-calculator-eoip/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ICU Trials Passes 100 Landmark Studies</title>
		<link>http://clincalc.com/blog/2015/04/icu-trials-passes-100-landmark-studies/</link>
		<comments>http://clincalc.com/blog/2015/04/icu-trials-passes-100-landmark-studies/#comments</comments>
		<pubDate>Sun, 19 Apr 2015 18:25:21 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[ClinCalc News]]></category>
		<category><![CDATA[ICU Trials]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=296</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2015/04/icutrials2-150x150.png" class="attachment-thumbnail wp-post-image" alt="Summarized landmark critical care trials on your mobile device" style="float: left; margin-right: 5px;" />ClinCalc.com is proud to announce that ICU Trials by ClinCalc, a mobile application that summarizes landmark critical care trials, has surpassed 100 studies in the app database! With our most recent update on April 18th, the following recent and historic landmark trials were added: MIDEX (2012): Dexmedetomidine vs. midazolam for mechanical ventilation PAC-Man (2005): Efficacy [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2015/04/icu-trials-passes-100-landmark-studies/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Speed Up Video Playback of The Top 250 Drugs Online Course</title>
		<link>http://clincalc.com/blog/2015/04/speed-up-video-playback-of-the-top-250-drugs-online-course/</link>
		<comments>http://clincalc.com/blog/2015/04/speed-up-video-playback-of-the-top-250-drugs-online-course/#comments</comments>
		<pubDate>Fri, 10 Apr 2015 01:52:11 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[ClinCalc News]]></category>
		<category><![CDATA[The Top 250 Drugs]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=290</guid>
		<description><![CDATA[<img width="128" height="128" src="http://clincalc.com/blog/wp-content/uploads/2015/04/vimeo128.png" class="attachment-thumbnail wp-post-image" alt="Increase Vimeo playback speed (Chrome extension)" style="float: left; margin-right: 5px;" />At ClinCalc.com, we&#8217;re huge fans of listening and watching educational content at a faster than normal pace. Unfortunately, the video provider used for The Top 250 Drugs (online drug therapy course) does not allow for the ability to change playback speed. Given our dedication to high-yield, rapid foundational learning, we&#8217;ve decided to build a free [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2015/04/speed-up-video-playback-of-the-top-250-drugs-online-course/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Top 250 Drugs &#8211; Online Pharmacotherapy Video Course</title>
		<link>http://clincalc.com/blog/2015/02/the-top-250-drugs-announcement/</link>
		<comments>http://clincalc.com/blog/2015/02/the-top-250-drugs-announcement/#comments</comments>
		<pubDate>Mon, 16 Feb 2015 18:11:10 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[ClinCalc News]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[The Top 250 Drugs]]></category>
		<category><![CDATA[Videos]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=279</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2015/02/2511020194_139e761626_crop-150x150.jpg" class="attachment-thumbnail wp-post-image" alt="The Top 250 Drugs" style="float: left; margin-right: 5px;" />ClinCalc.com has been a bit quiet over the past year.  Our Twitter account has been mute, email updates rare, and website updates sparse. Why the radio silence? We&#8217;ve been diligently working on an exciting new product for the past year.  Quite literally, HUNDREDS of hours have been poured into the conception, creation, and implementation of this amazing new product. [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2015/02/the-top-250-drugs-announcement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Incredible Update to Our Mobile Vancomycin Calculator (Android/iOS)</title>
		<link>http://clincalc.com/blog/2014/03/incredible-update-mobile-vancomycin-calculator-androidios/</link>
		<comments>http://clincalc.com/blog/2014/03/incredible-update-mobile-vancomycin-calculator-androidios/#comments</comments>
		<pubDate>Sat, 29 Mar 2014 22:04:40 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[ClinCalc News]]></category>
		<category><![CDATA[Mobile]]></category>
		<category><![CDATA[Pharmacokinetics]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=249</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2014/03/vanc3-150x150.png" class="attachment-thumbnail wp-post-image" alt="Vancomycin Calculator for Android and iOS Screenshot" style="float: left; margin-right: 5px;" />Advanced vancomycin pharmacokinetics equations has never been this easy. Our original Android-based Vancomycin Calculator was released in July 2011, followed a year later by our iPhone version.  In both mobile technology and the features of the ClinCalc.com website, a lot has changed in the last 2.5+ years. Today, we&#8217;re proud to announce a full redesign [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2014/03/incredible-update-mobile-vancomycin-calculator-androidios/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Really NEJM?  Shocking Failure of the Peer Review Process for the ALBIOS Trial</title>
		<link>http://clincalc.com/blog/2014/03/nejm-albios-review-failure/</link>
		<comments>http://clincalc.com/blog/2014/03/nejm-albios-review-failure/#comments</comments>
		<pubDate>Fri, 21 Mar 2014 03:01:57 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Landmark Trials]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=238</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2014/03/6798852475_1a3c0662b6_m-150x150.jpg" class="attachment-thumbnail wp-post-image" alt="Three nuts waiting to be cracked" style="float: left; margin-right: 5px;" />The New England Journal of Medicine released three landmark trials this week.  Each trial directly addresses controversies in sepsis management that have been debated for a decade or longer: high versus low MAP goals (SEPSISPAM), a challenge to early goal-directed therapy (ProCESS), and albumin replacement (ALBIOS). These trials will undoubtedly have a significant impact on [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2014/03/nejm-albios-review-failure/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>Visualizing the ACC/AHA ASCVD Pooled Cohort Equations</title>
		<link>http://clincalc.com/blog/2013/12/visualizing-the-ascvd-pooled-cohort-equations/</link>
		<comments>http://clincalc.com/blog/2013/12/visualizing-the-ascvd-pooled-cohort-equations/#comments</comments>
		<pubDate>Mon, 16 Dec 2013 00:28:42 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[ClinCalc News]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=215</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2013/12/ascvd2-150x150.png" class="attachment-thumbnail wp-post-image" alt="ASCVD Pooled Cohort Equations Visualization Tool - By Risk Factor" style="float: left; margin-right: 5px;" />The newest ACC/AHA ASCVD Pooled Cohort Equations has been a very hot topic lately.  Our free web-based ASCVD tool and mobile applications have been very well received.  A number of ClinCalc readers have asked for a better understanding of the Pooled Cohort Equations &#8212; how is an ASCVD calculated?  How &#8220;strong&#8221; is each risk factor? [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2013/12/visualizing-the-ascvd-pooled-cohort-equations/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>New Mobile and Web-Based 10-Year ASCVD Risk Calculator (Pooled Cohort Equations)</title>
		<link>http://clincalc.com/blog/2013/11/ascvd-risk-calc-mobile-and-web-based/</link>
		<comments>http://clincalc.com/blog/2013/11/ascvd-risk-calc-mobile-and-web-based/#comments</comments>
		<pubDate>Sat, 23 Nov 2013 12:49:32 +0000</pubDate>
		<dc:creator><![CDATA[Sean P. Kane]]></dc:creator>
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[ClinCalc News]]></category>

		<guid isPermaLink="false">http://clincalc.com/blog/?p=205</guid>
		<description><![CDATA[<img width="150" height="150" src="http://clincalc.com/blog/wp-content/uploads/2013/11/mobile-150x150.png" class="attachment-thumbnail wp-post-image" alt="ASCVD Calculator for Android and iOS" style="float: left; margin-right: 5px;" />At ClinCalc, we&#8217;re very proud to announce the availability of both a web-based and mobile-based (Android/iOS) 10-year ASCVD Risk Calculator (also termed the Pooled Cohort Equations Calculator).  This risk assessment tool is recommended by the newly published 2013 ACC/AHA cholesterol guidelines to estimate 10-year risk of atherosclerotic cardiovascular disease (ASCVD). Sweeping Changes to Cholesterol Guidelines These new [&#8230;]]]></description>
		<wfw:commentRss>http://clincalc.com/blog/2013/11/ascvd-risk-calc-mobile-and-web-based/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
	</channel>
</rss>
